CAS: 99-45-6; Adrenalone

该化合物是一种合成化合物,在结构上与乙酰胺,特别是肾上腺素有关,其特征是其基酮功能组和氢氧基体,有助于其再活性和生物活动.Adrenone一般是白色和白外白晶状粉,在有机溶剂中溶解,但在水中溶解有限.该化合物以其潜在的药理效应而著称,包括其对心血管系统的影响,在这种系统中,它可能起到同感性反应剂的作用.其化学特性使其与肾上腺素受体发生相互作用,并模拟自然催化素的影响.由于其与肾上腺素结构相似,乙酮还可能具有各种生理影响,包括心率和血压增加.然而,它在临床环境中的使用有限,而且主要是研究环境.当与许多化学物质合作时,安全和处理预防措施是必不可少的,因为安全与生物化合物具有重大的影响.

结构式图片

MSDS等安全信息

    上下游产品

    3,4-Dimethoxy-ω-methylaminoacetophenon N-(3,4-dimethoxy-phenacyl)-N-methyl-toluene-4-sulfonamideN-(3,4-dimethoxy-phenacyl)-N-methyl-toluene-4-sulfonamide 2-chloro-3',4'-dihydroxyacetophenone methylamine 4-(3,4-dihydroxy-phenyl)-1-methyl-1,3-dihydro-imidazol-2-one Epinephrine (S)-4-[1-hydroxy-2-(methylamino)ethyl]pyr°C atechol N-(2-(3,4-dihydroxyphenyl)-2-oxoethyl)-N-methylacetamide

    合成工艺路线路线简述

      📜肾上腺素置于(R)-Epinephrine Dehydrogenase,还原型辅酶ⅰ体系中,用 Aq. Phosphate Buffer 作为反应溶剂,化学反应生成 肾上腺酮
      参考文献:Purification And Characterization Of A Novel Carbonyl Reductase Involved In Oxidoreduction Of Aromatic β-Amino Ketones/alcohols
      标题:Purification And Characterization Of A Novel Carbonyl Reductase Involved In Oxidoreduction Of Aromatic β-Amino Ketones/alcohols
      摘要:Aromatic Beta-Amino Ketones/alcohols Such As Adrenalone Play An Important Role In Some Stereoselective Synthesis Of Pharmaceuticals. Unfortunately,The Transformation Of Aromatic Beta-Amino Ketones To Their Chiral Alcohols Has Been Carried Out Chemically As No Corresponding Biocatalyst Has Been Available. Here,A Novel Carbonyl Reductase Responsible For The Reduction Of Adrenalone To (R)-(-)-Epinephrine Was Identified And Characterized From Kocuria Rhizophila. This Enzyme Was Purified To Homogeneity By Ammonium Sulfate Precipitation Followed By Ion-Exchange Column Chromatography,Hydrophobic Chromatography And Gel Chromatography. The Purified Enzyme Yielded Pure (R)-Enantiomer Product With High Activity And Utilized Nadh As The Cofactor. The Enzyme Had Special Significance By Showing Selectivity For Many Aromatic Beta-Amino Ketones/alcohols Such As 2-Amino-Acetophenone,2-Amino-4'-Hydroxyacetophenone,Isoproterenol And Ephedrine. The Maximum Reaction Rate (V-Max) And Apparent Michaelis-Menten Constant (K-M) For Adrenalone And Nadh Were 14.62 Mu Mol/(Min Mg) Protein And 0.189 Mm,11.66 Mu Mol/(Min Mg) Protein And 0.204 Mm Respectively. These Properties Ensure The Enzyme A Promising Future For Industrial Application As A Replacement Of Chemical Synthesis Of Aromatic Beta-Amino Chiral Alcohols. (C) 2014 Elsevier Ltd. All Rights Reserved.
      DOI:10.1016/j.Procbio.2014.03.023

      海关参考信息

      专利信息


      专利号:US-9353057-B2
      优先权日:2003-12-30
      标 题:Synthesis of acyloxyalkyl carbamate prodrugs and intermediates thereof
      发明人:GALLOP MARK A; DAI XUEDONG; SCHEUERMAN RANDALL A; RAILLARD STEPHEN P; MANTHATI SURESH K; YAO FENMEI; PHAN THU; LUDWIKOW MARIA; PENG GE; BHAT SEEMA
      权利人:XENOPORT INC
      摘要:Methods for synthesis of 1-(acyloxy)-alkyl carbamates, particularly, the synthesis of 1-(acyloxy)-alkyl carbamate prodrugs of primary or secondary amine-containing drugs are described. Also described are methods for synthesis of 1-(acyloxy)-alkyl N-hydroxysuccinimidyl carbonates which are useful intermediates in the synthesis of 1-(acyloxy)-alkyl carbamates are also described.

      专利号:US-2021061757-A1
      优先权日:2018-04-13
      标题:Process for the synthesis of optically active beta-amino alcohols
      发明人:NISIC FILIPPO; GARIS FARIS; COLLI CORRADO; BERTOLINI GIORGIO; SADA MARA; BERTUOLO STEFANIA; RONZONI SILVANO; DI FABIO ROMANO; MAIORANA STEFANO
      权利人:OLON SPA
      摘要:Subject-matter of the present invention is a process for the preparation of optically active phenyl-beta-amino alcohols by means of a specific reduction of the corresponding phenyl-beta-amino ketones. Further subject-matter of the invention are said novel synthesis intermediates and their use for the preparation of active pharmaceutical ingredients.

      专利号:WO-2025058704-A1
      优先权日:2023-09-15
      标 题:Process for the preparation of epinephrine and norepinephrine
      发明人:YUE TAI-YUEN; SAHANI RAJKUMAR; JAYARAMAN ARAVINDAN; DONSBACH KAI; SENANAYAKE CHRIS; QU BO; SIRASANI GOPAL; MANGUNURU HARI; JANGANATI VENUMADHAV; GANGU ARAVIND; TERRAB LEILA; KALIKINIDI NAGESWARA
      权利人:UNIV VIRGINIA COMMONWEALTH
      摘要:A method of preparing epinephrine or norepinephrine is provided. The method includes reacting a starting material comprising 2-chloro-l-(3,4-dihydroxyphenyl)ethan-l- one with an amine nucleophile RNH2 (R=H for the synthesis of epinephrine or Me for the synthesis of norepinephrine) under conditions suitable for nucleophilic substitution of the starting material to form a substituted starting material and reacting the substituted starting material with a tethered ligand transition metal catalyst under conditions suitable for transfer¬ hydrogenation to produce epinephrine or norepinephrine.

      专利号:US-8017776-B2
      优先权日:2003-07-15
      标题 :Methods for synthesis of acyloxyalkyl compounds
      发明人:BHAT LAXMINARAYAN; GALLOP MARK A
      权利人:XENOPORT INC
      摘要:Disclosed herein are methods for synthesizing 1-(acyloxy)-alkyl prodrug derivatives of drugs through oxidation of 1-acyl-alkyl derivatives of drugs under anhydrous reaction conditions. The methods typically proceed stereospecifically, in high yield, do not require the use of activated intermediates and/or toxic compounds and are readily amenable to scale-up.

      专利号:US-2005080260-A1
      优先权日:2003-04-22
      标 题 :Preparation of prodrugs for selective drug delivery
      发明人:MILLS RANDELL L; WU GUO-ZHANG
      摘要:Synthesis of a chemical compound having the formula A-B-C that may serve for applications such as drug delivery where A is a chemiluminescent, moiety, B is a photochromic moiety, and C is a biologically active moiety where A-B-C may serve as a prodrug. Novel synthetic methods of the present invention to form the prodrug comprised the steps of (1) forming a benzophenone, (2) forming a diaryl ethylene, (3) attaching a phthalimide moiety to at least one of the aryl groups of the ethylene to form a phthalimide-ethylene conjugate, (4) condensing two ethylene-phthalimide conjugates to form a phthalimide-pentadiene conjugate, (5) converting the phthalimide to the phthalhydrazide by reaction with hydrazine to form a carrier compound according to the present invention, and (6) reacting the carrier compound with an nucleophilic moiety of the drug to form the corresponding prodrug. Alternatively the carrier can be prepared by using the halo-substituted diaryl ethylene to make the corresponding cationic leuco dye-like compound with known methods. The cationic compound then is protected by reacting with a nucleophile and coupled with the aminophathalimide by palladium-catalyzed amination to form the protected phthalimide-pentadiene conjugate. The latter is refluxed with hydrazine to convert its phthalimide to the phthalhydrazide and acidified to give the carrier. An additional aspect of the present invention relates to the use of these compounds as antiviral agents for the treatment of viral infections such as HIV and as anticancer agents for the treatment of cancers such as bowel, lung, and breast cancer.

      专利号:US-2015158809-A9
      优先权日:2013-02-26
      标 题 :Method of making 1-(acyloxy)-alkyl carbamate compounds
      发明人:WANG HUAN; LIU PENG; DAI QUNYING; YIN HAO; RAILLARD STEPHEN P
      权利人:XENOPORT INC
      摘要:Methods of preparing carbamate prodrugs of amine-containing drugs are provided. Carbonates useful in the synthesis of the carbamate prodrugs are also provided.

      供应商参考报价(招募中)

      品牌试剂参考报价(招募中)

      📌 第三方产品分析报告

      ✅ COA系统入驻 | 共享模式

      主要参考文献


      1: Kulinskiĭ VI, Iashunskiĭ VG, Klimova AD, Alpatova TV. [Radiation protective effect of beta-ketoanalogs of hydroxyphenyl ethanolamines]. Radiats Biol Radioecol. 1997 Nov-Dec;37(6):914-7. Russian. doi: 10.1023/A:1016348624897. J Physiol (Paris). 1965 May-Jun;57(3):399-406. French. German. German. German. Undetermined Language. Undetermined Language. Therapie. 1953;8(3):224-30. Undetermined Language. Undetermined Language. Undetermined Language.

      合成参考文献


      摘要:Naunyn-Schmiedeberg's Archiv fuer Experimentelle Pathologie und Pharmakologie., 226(493), 1955 []
      摘要:S109 | PARCEDC | List of 7074 potential endocrine disrupting compounds (EDCs) by PARC T4.2 | DOI:10.5281/zenodo.10944198
      📝 需求与反馈
      尽可能描述清楚需求与问题信息
      ×

      通知